Hypertension (Dallas, Tex. : 1979)
Efficacy and Safety of Treatment With Low Doses of Spironolactone in Patients With Primary Aldosteronism: A Retrospective Observational Study in a Tertiary Center.
Elisa Sconfienza, Julien Riancho, Nicole Gebara, Diana Ferrão, Jacopo Burrello, Jean-Baptiste de Freminville, Elisa Deflorenne, Aurélien Lorthioir, Michel Azizi, Laurence Amar
Published: 202610.1161/HYPERTENSIONAHA.125.24881
Abstract
BACKGROUND: Spironolactone is recommended as first-line therapy for patients with idiopathic primary aldosteronism. The aim of this study is to evaluate the impact of low and high doses of spironolactone on arterial blood pressure control, potassium…
Preview only. Read the full abstract at the source